OSIRIS THERAPEUTICS, INC. 4
4 · OSIRIS THERAPEUTICS, INC. · Filed Feb 7, 2014
Insider Transaction Report
Form 4
Debrabandere Lode
Vice President
Transactions
- Award
Incentive Stock Option (right to buy)
2014-02-06$14.93/sh+10,199$152,271→ 232,699 totalExercise: $14.93From: 2015-02-06Exp: 2024-02-06→ Common Stock (10,199 underlying) - Award
Non-Qualified Stock Option (right to buy)
2014-02-06$14.93/sh+139,801$2,087,229→ 372,500 totalExercise: $14.93From: 2015-02-06Exp: 2024-02-06→ Common Stock (139,801 underlying)